D.E. Shaw & Co
LIMNW

D.E. Shaw & Co’s Liminatus Pharma Warrants LIMNW Stock Holding History

D.E. Shaw & Co’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33K Hold
83,353
– – ﹤0.01% 4450
2025
Q4 		$2.92K Hold
83,353
– – ﹤0.01% 4539
2025
Q3 		$10K Hold
83,353
– – ﹤0.01% 4465
2025
Q2 		$20.2K Buy
+83,353
New +$16.4K ﹤0.01% 4223

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

D.E. Shaw & Co's LIMNW Position: Q1 2026 in Review

D.E. Shaw & Co held its Liminatus Pharma Warrants (LIMNW) position steady in Q1 2026 at 83,353 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4450.

D.E. Shaw & Co first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.2K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • D.E. Shaw & Co held 83,353 shares of Liminatus Pharma Warrants worth $3.33K as of Q1 2026.
  • D.E. Shaw & Co left its Liminatus Pharma Warrants share count unchanged in Q1 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4450 holding.
  • D.E. Shaw & Co first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • D.E. Shaw & Co's Liminatus Pharma Warrants position peaked at $20.2K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.